课题基金 / 基金详情

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
帕金森病基因修饰的机制分析
批准号:
10612362
负责人:
DIMITRI KRAINC
金额:
$120.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2029-04-30

项目摘要

项目成果

DIMITRI KRAINC的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 我认为,将疾病基因发现方法与深入的后续机制和 功能研究是我研究项目的一个独特方面。我们最近发现的“人类特有的”通路 中脑DA神经元的表型(与小鼠相比)使我们专注于患者来源的DA神经元 研究PD相关基因的功能。通过采用iPS来源的神经元、小胶质细胞和 星形胶质细胞,我们将研究细胞自主和非细胞自主通路之间的相互作用,这些通路导致 帕金森病患者中脑DA神经元功能障碍。此外,我们还将利用创新技术,同时 用综合iPS方法检查大量的遗传变异,这在以前是不可能的。 最后,我们最近发现的溶酶体和线粒体之间的直接接触打开了一个完全 研究神经退行性变的细胞器间和细胞器内动力学的新机会。R35奖将 给我时间、自由和稳定,让我变得更加冒险,并一如既往地遵循最 有趣的生物学对这一领域产生了很大的影响。
英文摘要
Summary I believe that combining disease gene discovery approaches with in-depth follow-up mechanistic and functional studies is a unique aspect of my research program. Our recent discovery of “human-specific” pathways and phenotypes (compared to mice) in midbrain DA neurons has led us to focus on patient-derived DA neurons to examine the function of PD-linked genes. By employing co-cultures of iPS-derived neurons, microglia and astrocytes, we will examine the interplay of cell-autonomous and no-cell autonomous pathways that lead to dysfunction of midbrain DA neurons in PD. Moreover, we will use innovative technology to simultaneously examine a large number of genetic variants in a pooled iPS approach that has not been possible previously. Finally, our recent discovery of direct contacts between lysosomes and mitochondrial has opened a completely new opportunity to examine inter- and intra-organellar dynamics in neurodegeneration. The R35 award would provide me the time, freedom and stability to be even more adventurous and, as always, follow the most interesting biology to have a high impact on the field.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
Functional investigation of the role of TYR mutations and neuromelanin in Parkinson's disease
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein
海外基金